Healthcare -
Biotechnology - NASDAQ - US
$ 8.09
-1.17 %
$ 838 M
Market Cap
-1.45
P/E
NTLA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NTLA - Intellia Therapeutics, Inc.
186 M
LAST VALUE
-43.55%
2 YEAR CAGR
19.43%
5 YEAR CAGR
25.53%
10 YEAR CAGR